Exclusive: ACR Convergence 2024| Focus Rheums

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Guidance

Subcategories:Clinical Criteria/GuidelinesEthicsLegal UpdatesLegislation & AdvocacyMeeting ReportsResearch Rheum

Everybody Is Doing It: Are You an Advocate?

  |  

This month, the ACR board of directors is on Capitol Hill. As leaders of the organization, they have heard the cry of their membership and are dedicating time to address the concerns of the rheumatology community with Congress.

The Future of Medicine Is in Washington—You Should Be, Too

  |  

On March 10, the ACR hosted its 2009 “Advocates for Arthritis” fly-in. During this event, over 100 rheumatologists, rheumatology health professionals, and patient advocates walked the halls of Congress to lobby legislators on important issues affecting the rheumatology community.

Streamlined Funding Portfolio Increases Efficacy

  |  

The ACR Research and Education Foundation recently completed a comprehensive review of its core awards and grants portfolio to assure that it was effective in meeting the needs of junior or early career physician-scientists and health professionals.

Reading Rheum

Eric Schned, MD; Michael M. Ward, MD  |  

Handpicked Reviews of Contemporary Literature

Sense of Smell

Yehuda Shoenfeld, MD  |  

Olfactory defects point to nervous system involvement in lupus

The Arthritis Act: Where Is It Now? What Can I Do?

  |  

In September 2008, the “Arthritis Prevention, Control, and Cure Act” passed the House of Representatives. Unfortunately this legislation failed to pass through the Senate and did not become a law. (The Arthritis Act had to be passed in both congressional chambers and signed by the president for the bill to become law.)

Demonstrators Demand More Money for Arthritis Research—What Could Happen?

Leslie Crofford, MD  |  

I recently came across a fictional publication called the Not Yet Gazette with a front-page story dated November 10, 2025, entitled, “Demonstrators demand more money for arthritis research.” The fictional report gave details of a crowd of 100,000, “many in wheelchairs,” confronting the health secretary of that time. The genesis of this fictional article was the observed trend towards the aging of the population and slow growth in research funding. The article stated that, “ ‘Fiscal constraints caused by slow economic growth and resistance to tax increases have greatly reduced allocations for medical research grants in recent years,’ [the health secretary] told the delegates. ‘Unfortunately, in our current political climate, funding for health research is limited,’ she said to reporters after the meeting. ‘We have to devote our limited resources to diseases that are more immediately life-threatening.’ ”

Change on the Mall

David S. Pisetsky, MD, PhD  |  

Will an election driven by change bring agreeable—and affordable—healthcare reform?